After Amgen last year asked the Supreme Court to take up its long-running PCSK9 patent feud with Sanofi and Regeneron, the High Court turned to the federal government to weigh in. Now, the Biden administration says the court should turn down the California drugmaker's request to take up the case.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,